SCHEMBL15469804

SCHEMBL15469804

CCCC[C@H](N)C[C@@H](C)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.45
OPRM1 P35372 1/20 0.42
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
TP53 P04637 2/20 0.39
S1PR2 O95136 5/20 0.38
S1PR1 P21453 5/20 0.38
S1PR3 Q99500 5/20 0.38
S1PR4 O95977 4/20 0.38
SLC15A1 P46059 1/20 0.38
CYP2D6 P10635 2/20 0.38
PLA2G1B P04054 1/20 0.38
PLA2G2A P14555 1/20 0.38
GMNN O75496 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6730336 0.93 SPHK1 (0.54) SPHK1OPRM1SLC1A2SLC1A1TP53
SCHEMBL8686091 0.91 SPHK1 (0.57) SPHK1OPRM1TP53S1PR2S1PR1
SCHEMBL8685810 0.91 SPHK1 (0.57) SPHK1OPRM1TP53S1PR2S1PR1
SCHEMBL8686872 0.91 SPHK1 (0.57) SPHK1OPRM1TP53S1PR2S1PR1
SCHEMBL8688268 0.91 SPHK1 (0.57) SPHK1OPRM1TP53S1PR2S1PR1
SCHEMBL8686851 0.91 SPHK1 (0.57) SPHK1OPRM1TP53S1PR2S1PR1
SCHEMBL8685960 0.91 SPHK1 (0.57) SPHK1OPRM1TP53S1PR2S1PR1
Hydrochloric Acid SCHEMBL6912434 0.89 SPHK1 (0.55) SPHK1OPRM1TP53S1PR2S1PR1
SCHEMBL6545580 0.85
SCHEMBL4566710 0.82 OPRM1 (0.46) SPHK1OPRM1SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180207155-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS JANSSEN SCIENCES IRELAND UC (IE) 2018-07-26 US disclosed
US-9422250-B2 Pyrimidine derivatives for the treatment of viral infections JANSSEN SCIENCES IRELAND UC (IE) 2016-08-23 US disclosed
US-20140045849-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS JANSSEN SCIENCES IRELAND UC (IE) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045849-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS TYMP, UMPS, HPRT1 SPHK1 1425/4885OPRM1 4002/4885SLC1A3 3925/4885
US-20180207155-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS TYMP, UMPS, HPRT1 SPHK1 1425/4885OPRM1 4002/4885SLC1A3 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.